NEW YORK–(BUSINESS WIRE)–Faruqi & Faruqi, LLP, a leading national securities law firm, reminds
investors in Amyris, Inc. (“Amyris” or the “Company”) (NASDAQ:AMRS) of
the June 3, 2019 deadline to seek the role of lead plaintiff in a
federal securities class action that has been filed against the Company.
If you invested in Amyris stock or options between March 15, 2018 and
March 19, 2019 and would like to discuss your legal rights, click
here: www.faruqilaw.com/AMRS.
There is no cost or obligation to you.
You can also contact us by calling Richard Gonnello toll free at
877-247-4292 or at 212-983-9330 or by sending an e-mail to [email protected].
The lawsuit has been filed in the U.S. District Court for the Northern
District of California on behalf of all those who purchased Amyris
securities between March 15, 2018 and March 19, 2019 (the “Class
Period”). The case, Mulderrig et al v. Amyris, Inc. et al, No.
19-cv-01765 was filed on April 3, 2019, and has been assigned to Judge
Yvonne Gonzalez Rogers.
The lawsuit focuses on whether the Company and its executives violated
federal securities laws by making false and/or misleading statements
and/or failing to disclose: (1) that the company lacked sufficient
resources to accurately account for certain transactions; (2) that, as a
result, there was a material weakness in the company’s internal controls
over financial reporting; (3) that, as a result, the company would be
unable to timely file its annual report; and (4) that, as a result of
the foregoing, defendants’ positive statements about the company’s
business, operations, and prospects were materially misleading and/or
lacked a reasonable basis.
On November 13, 2018 when the Company reported poor financial results,
which it attributed to the “volatility of the Vitamin E market.”
On this news, the Company’s stock price fell from $5.90 per share on
November 13, 2019 to $4.14 per share on November 14, 2019–a $1.76 or
29.83% drop.
Then, on March 19, 2019, after the market closed, the Company filed a
Notification of Late Filing on Form 12b-25 with the Securities and
Exchange Commission (“SEC”).
On this news, the Company’s stock price fell from $3.88 per share on
March 19, 2019 to $3.10 per share on March 20, 2019—a $0.78 or 20.10%
drop.
The court-appointed lead plaintiff is the investor with the largest
financial interest in the relief sought by the class who is adequate and
typical of class members who directs and oversees the litigation on
behalf of the putative class. Any member of the putative class may move
the Court to serve as lead plaintiff through counsel of their choice, or
may choose to do nothing and remain an absent class member. Your ability
to share in any recovery is not affected by the decision to serve as a
lead plaintiff or not.
Faruqi & Faruqi, LLP also encourages anyone with information regarding
Amyris’ conduct to contact the firm, including whistleblowers, former
employees, shareholders and others.
Attorney Advertising. The law firm responsible for this advertisement is
Faruqi & Faruqi, LLP (www.faruqilaw.com).
Prior results do not guarantee or predict a similar outcome with respect
to any future matter. We welcome the opportunity to discuss your
particular case. All communications will be treated in a confidential
manner.
Contacts
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New
York, NY 10017
Attn: Richard Gonnello, Esq.
[email protected]
Telephone:
(877) 247-4292 or (212) 983-9330
